1.
Muscogiuri G, Annweiler C, Duval G, Karras S, Tirabassi G, Salvio G, Balercia G, Kimball
S, Kotsa K, Mascitelli L et al. Vitamin D and cardiovascular disease: From atherosclerosis to myocardial infarction
and stroke. Int J Cardiol. 2017;230:577-84.
2.
Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-81.
3.
Scott D, Ebeling PR. Vitamin D and Public Health. Int J Environ Res Public Health.
2019;16.
4.
Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, Creager MA,
Culebras A, Eckel RH, Hart RG et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals
from the American Heart Association/American Stroke Association. Stroke. 2011;42:517-84.
5.
Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran
AE, Sacco RL, Anderson L, Truelsen T et al. Global and regional burden of stroke during 1990-2010: findings from the Global
Burden of Disease Study 2010. Lancet. 2014;383:245-54.
6.
Sun Q, Pan A, Hu FB, Manson JE, Rexrode KM. 25-Hydroxyvitamin D levels and the risk
of stroke: a prospective study and meta-analysis. Stroke. 2012;43:1470-7.
7.
Kiggundu DS, Mutebi E, Kibirige D, Boxer R, Kakande B, Kigozi BK, Katabira E. Vitamin
D deficiency and its characteristics among patients with acute stroke at a national
referral hospital in Kampala Uganda. BMC Endocr Disord. 2015;15:53.
8.
Majumdar V, Prabhakar P, Kulkarni GB, Christopher R. Vitamin D status, hypertension
and ischemic stroke: a clinical perspective. J Hum Hypertens. 2015;29:669-74.
9.
Afzal S, Nordestgaard BG. Vitamin D, Hypertension, and Ischemic Stroke in 116 655
Individuals From the General Population: A Genetic Study. Hypertension. 2017;70:499–507.
10.
Li J, Lai H, Yang L, Zhu H, Chen S, Lai S. Age and Gender Differences in the Association
between Serum 25-Hydroxyvitamin D and Stroke in the General US Population: The National
Health and Nutrition Examination Survey, 2001-2006. J Stroke Cerebrovasc Dis. 2017;26:2510-8.
11.
Xu T, Zhong C, Xu T, Peng Y, Bu X, Chen CS, Wang J, Ju Z, Li Q, Geng D et al. Serum 25-hydroxyvitamin D deficiency predicts long-term poor prognosis among ischemic
stroke patients without hyperglycaemia. Clin Chim Acta. 2017;471:81-5.
12.
Brondum-Jacobsen P, Nordestgaard BG, Schnohr P, Benn M. 25-hydroxyvitamin D and symptomatic
ischemic stroke: an original study and meta-analysis. Ann Neurol. 2013;73:38-47.
13.
Alfieri DF, Lehmann MF, Oliveira SR, Flauzino T, Delongui F, de Araujo MC, Dichi I,
Delfino VD, Mezzaroba L, Simao AN et al. Vitamin D deficiency is associated with acute ischemic stroke, C-reactive protein,
and short-term outcome. Metab Brain Dis. 2017;32:493-502.
14.
Sato Y. Abnormal bone and calcium metabolism in patients after stroke. Arch Phys Med
Rehabil. 2000;81:117-21.
15.
Yoo K, Cho J, Ly S. Vitamin D Intake and Serum 25-Hydroxyvitamin D Levels in Korean
Adults: Analysis of the 2009 Korea National Health and Nutrition Examination Survey
(KNHANES IV-3) Using a Newly Established Vitamin D Database. Nutrients. 2016;8:E610.
16.
Nimitphong H, Holick MF. Vitamin D status and sun exposure in southeast Asia. Dermatoendocrinol.
2013;5:34-7.
17.
Lips P. Relative value of 25(OH)D and 1,25(OH)2D measurements. J Bone Miner Res. 2007;22:1668-71.
18.
Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA,
Gallagher JC, Gallo RL, Jones G et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the
Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53-8.
19.
Hwang YC, Ahn HY, Jeong IK, Ahn KJ, Chung HY. Optimal serum concentration of 25-hydroxyvitamin
D for bone health in older Korean adults. Calcif Tissue Int. 2013;92:68-74.
20.
Kwon YJ, Kim SE, Park BJ, Bae JW, Kang HT. High-risk drinking is associated with dyslipidemia
in a different way, based on the 2010-2012 KNHANES. Clin Chim Acta. 2016;456:170-5.
21.
Fogelholm M, Malmberg J, Suni J, Santtila M, Kyrolainen H, Mantysaari M, Oja P. International
Physical Activity Questionnaire: Validity against fitness. Med Sci Sports Exerc. 2006;38:753-60.
22.
Xu T, Zhong C, Peng Y, Chen CS, Wang J, Ju Z, Li Q, Geng D, Sun Y, Zhang D et al. Serum 25-hydroxyvitamin D deficiency predicts poor outcome amongst acute ischaemic
stroke patients with low high density lipoprotein cholesterol. Eur J Neurol. 2016;23:1763-8.
23.
Ji W, Zhou H, Wang S, Cheng L, Fang Y. Low Serum Levels of 25-Hydroxyvitamin D Are
Associated with Stroke Recurrence and Poor Functional Outcomes in Patients with Ischemic
Stroke. J Nutr Health Aging. 2017;21:892-6.
24.
Wrzosek M, Lukaszkiewicz J, Wrzosek M, Jakubczyk A, Matsumoto H, Piatkiewicz P, Radziwon-Zaleska
M, Wojnar M, Nowicka G. Vitamin D and the central nervous system. Pharmacol Rep. 2013;65:271-8.
25.
Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D
receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29:21-30.
26.
Buell JS, Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing "D"ecline?
Mol Aspects Med. 2008;29:415-22.
27.
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative
endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:229-38.
28.
Borges AC, Feres T, Vianna LM, Paiva TB. Effect of cholecalciferol treatment on the
relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension.
1999;34:897-901.
29.
Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin
D supplementation improves cytokine profiles in patients with congestive heart failure:
a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83:754-9.
30.
Choi HS, Oh HJ, Choi H, Choi WH, Kim JG, Kim KM, Kim KJ, Rhee Y, Lim SK. Vitamin D
insufficiency in Korea--a greater threat to younger generation: the Korea National
Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab. 2011;96:643-51.
31.
Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc
Dis. 2003;46:11-29.
32.
Silvestrini M, Troisi E, Matteis M, Cupini LM, Bernardi G. Effect of smoking on cerebrovascular
reactivity. J Cereb Blood Flow Metab. 1996;16:746-9.
33.
Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, Nieto FJ, Tell
GS. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk
in Communities (ARIC) Study. JAMA. 1998;279:119-24.